The role of cadherins and catenins in endometrial function and embryo implantation: A comprehensive review
Article information
Abstract
Cadherins and catenins are essential transmembrane proteins and cytoplasmic binding partners that mediate cell–cell adhesion, intracellular signaling, and the maintenance of tissue architecture. Their coordinated functions are central to endometrial biology and embryo implantation, a process that requires complex cell–cell interactions and tissue remodeling for pregnancy to be established. In this review, we summarize current evidence on the molecular mechanisms through which cadherins and catenins regulate endometrial receptivity and support embryo attachment to maternal tissue. We also discuss how advances in molecular biology and reproductive medicine have clarified the roles of cadherin–catenin complexes in cell adhesion, intracellular signaling, including Wnt/β-catenin signaling, and the regulation of trophoblast invasion. In addition, we examine the potential clinical relevance of dysfunction in these complexes, which has been associated with implantation failure and infertility. A clearer understanding of cadherin–catenin function in the endometrium may support the development of diagnostic tools and therapeutic targets for infertility.
Introduction
At the cellular level, trophoblasts derived from the blastocyst invade the endometrium during implantation [1]. This attachment process is essential in mammals [2], occurs in a spatiotemporally regulated manner, and is coordinated by morphological and immunological events. The embryo–maternal endometrial interface depends on the precise regulation of adhesion molecules, signaling pathways, and structural proteins [3,4]. Among these mediators, cadherins and catenins contribute to cell adhesion, tissue remodeling, and signal transduction during implantation (Table 1) [5,6]. Their principal mechanisms of action are summarized in Figure 1.
Cadherins and catenins involved in embryonic implantation: expression, signaling pathways, experimental evidence, and clinical associations
Molecular mechanisms of cadherin–catenin complexes in endometrial function and embryo implantation. JAK, Janus kinase; STAT3, signal transducer and activator of transcription 3; LIF, leukemia inhibitory factor; VEGF, vascular endothelial growth factor; uNK, uterine natural killer cells; IL, interleukin; TGFβ, transforming growth factor-β; MMP, matrix metalloproteinase; TIMP, tissue inhibitor of metalloproteinases; HOXA, homeobox A; VE, vascular endothelial.
Methods
This narrative review, supported by a structured literature search, was conducted to synthesize current evidence on the roles of cadherins and catenins in endometrial function and embryo implantation. The review was not designed as a systematic review and was not prospectively registered. A structured search strategy was used to improve the transparency and reproducibility of literature retrieval, whereas the synthesis and interpretation of findings retained the flexibility of a narrative approach. PubMed, Cochrane Library, and Web of Science were searched to identify relevant publications available up to October 2025. No strict publication-date restriction was applied; however, particular emphasis was placed on studies published within the last two decades and on recent high-impact publications from 2020 to 2025 to ensure contemporary relevance.
The search strategy combined controlled vocabulary and free-text terms, including ‘cadherin,’ ‘catenin,’ ‘E-cadherin,’ ‘N-cadherin,’ ‘β-catenin,’ ‘Wnt signaling,’ ‘endometrium,’ ‘embryo implantation,’ ‘decidualization,’ ‘trophoblast invasion,’ and ‘endometrial receptivity.’ Boolean operators were applied to refine the search results. Additional articles were identified through manual screening of the reference lists of selected studies.
The initial search yielded 1,171 records. After duplicate records were removed, 353 titles and abstracts were independently screened by two authors for relevance. Subsequently, 87 full-text articles were assessed, and 49 studies were included in the qualitative synthesis (Figure 2). Full-text articles were excluded if they lacked direct relevance to implantation biology, focused primarily on oncological or non-reproductive contexts, did not provide original or review data, or contained insufficient methodological detail for critical appraisal.
Eligible studies included original research articles, systematic reviews, meta-analyses, and relevant narrative reviews addressing molecular, physiological, pathological, or clinical aspects of cadherin–catenin signaling in implantation biology. Human studies and experimental investigations using animal models or in vitro/ex vivo systems were considered when they provided mechanistic or translational insights into endometrial function. Publications not directly related to implantation biology, non-English articles, and conference abstracts without full data were excluded. Studies focused exclusively on non-uterine tissues or unrelated pathological conditions were also excluded to maintain biological relevance to embryo implantation.
The overall strength of the evidence was qualitatively assessed by considering study design, experimental model, sample size, reproducibility, and consistency of findings across species and systems. Particular attention was given to distinguishing mechanistic data derived from animal models from observational or correlative findings obtained from human clinical samples, allowing the translational relevance of the evidence to be appraised more critically. Discrepancies across experimental systems were also noted and incorporated into the critical synthesis.
1. Cadherins in embryo implantation
Cadherins are calcium-dependent transmembrane glycoproteins that mediate homophilic cell–cell adhesion and are critical for tissue morphogenesis and homeostasis [7,8]. During implantation, cadherin subtypes show distinct expression patterns and appear to have different functional roles.
1) E-cadherin
E-cadherin is predominantly expressed in epithelial cells and helps maintain epithelial integrity in the endometrium [9]. During the pre-implantation window, E-cadherin preserves the integrity of the luminal epithelium and contributes to the physical barrier that prevents premature embryo attachment [10]. Near the window of implantation, localized downregulation of E-cadherin at the implantation site permits trophoblasts to breach the epithelial barrier [11]. Paria et al. [12] demonstrated an association between loss of E-cadherin expression at the blastocyst stage and implantation failure in mouse models, supporting the established role of E-cadherin in implantation. E-cadherin expression has also been reported to be reduced or altered in patients with recurrent miscarriage [13].
2) N-cadherin
N-cadherin is preferentially expressed in mesenchymal cells, and its expression increases in the endometrial stroma during decidualization [14]. Wu et al. [15] reported that N-cadherin mediates stromal-cell migration and differentiation, both of which are required for decidual development. These processes help provide the developing embryo with nutritional support and an immunologically privileged environment [15]. In mouse models, N-cadherin knockout has been associated with impaired decidualization and subsequent embryo rejection during the implantation window [16].
3) P-cadherin
Cadherin subtype switching contributes to the regulation of trophoblast invasion at the endometrial epithelium [17,18]. At the maternal-fetal interface, differential cadherin expression appears to regulate the depth of trophoblast invasion, thereby limiting excessive penetration and reducing the likelihood of placental complications. Aberrant P-cadherin expression has been associated with clinically important pathological conditions, including placenta accreta and preeclampsia [19,20].
4) Vascular endothelial-cadherin
Vascular endothelial (VE)-cadherin is expressed primarily in VE cells, where it contributes to endothelial intercellular junction integrity, vascular permeability, and angiogenesis during implantation [21]. Sung et al. [22] demonstrated, in a murine model, that VE-cadherin, although classically an endothelial protein, is also expressed by invading trophoblasts, where it mediates endovascular invasion and remodeling of maternal spiral arteries, thereby enabling the increased blood flow required for successful placentation. Disruption of endothelial VE-cadherin function has been associated with defective angiogenesis [23], and analogous disruption of trophoblast VE-cadherin would be expected to contribute to placental vascular malformations.
2. Cadherin switching as a unifying theme: critical evaluation of the evidence
Taken together, the expression dynamics of cadherin subtypes during implantation are consistent with a partial, spatially regulated epithelial-to-mesenchymal transition. The sequential downregulation of E-cadherin and upregulation of N-cadherin at the maternal–fetal interface mirrors the cadherin switching described in developmental and oncological contexts [19,24]. However, most mechanistic evidence supporting causal roles for individual cadherin subtypes comes from murine knockout models, which may not fully reproduce human implantation physiology because uterine architecture and implantation strategies differ substantially across species. Human data remain largely observational and correlative, and they are often derived from endometrial biopsies in heterogeneous clinical populations. Therefore, the extent to which species-specific findings can be translated to human reproductive biology requires careful interpretation, particularly when findings are extrapolated to clinical contexts.
3. Catenins in embryo implantation
Catenins are cytoplasmic proteins that bind to the intracellular domains of cadherins, linking them to the actin cytoskeleton and supporting signal transduction [25]. Four major catenins—α-catenin, β-catenin, γ-catenin, and p120-catenin—may have distinct roles during embryo implantation [26,27].
1) α-Catenin
α-Catenin mechanically links the cadherin–β-catenin complex to the actin cytoskeleton, thereby conferring structural stability on adherens junctions [28,29]. Singh et al. [30] demonstrated that α-catenin expression in the endometrial epithelium is critical for preserving tissue integrity during the early stages of implantation. Loss of α-catenin function compromises epithelial barrier integrity and is associated with abnormal embryo attachment [31].
2) β-Catenin
β-Catenin functions both as a structural component of adherens junctions and as a principal effector of the canonical Wnt signaling pathway during embryo implantation [32]. Zavareh et al. [33] demonstrated that Wnt/β-catenin target genes involved in proliferation, differentiation, and angiogenesis are differentially expressed in the uterus across the reproductive cycle. Mohamed et al. [34] reported that abnormal β-catenin signaling is correlated with implantation dysfunction and early pregnancy loss. Recent high-resolution transcriptomic and single-cell RNA-sequencing studies have refined the cellular understanding of endometrial receptivity. A single-cell transcriptomic atlas of the human endometrium showed that the window of implantation corresponds to distinct epithelial and stromal transcriptional transitions characterized by coordinated activation of signaling pathways, including Wnt-related networks [35]. More recently, integrative single-cell reference atlases have further delineated cell-type-specific gene-expression programs across the menstrual cycle, highlighting dynamic regulation of adhesion molecules and pathway interactions that may be linked to cadherin–catenin complexes [36].
Time-series single-cell analyses of luteal-phase endometrium have identified dysregulated signaling trajectories in women with recurrent implantation failure (RIF), including altered epithelial differentiation and stromal decidual responses [37]. Spatial transcriptomic studies have further identified region-specific transcriptional abnormalities in RIF endometrium, suggesting that disrupted intercellular signaling and adhesion remodeling may contribute to impaired receptivity [38,39]. Although these datasets do not focus exclusively on Wnt/β-catenin signaling, they support the concept that aberrant pathway activation and altered integration of adhesion signaling are central components of implantation failure in humans.
Although single-cell and spatial datasets substantially enrich mechanistic understanding, they are predominantly cross-sectional and correlative, and most lack functional validation of the specific cadherin–catenin pathways they implicate. Longitudinal studies with standardized definitions of implantation failure and prospective functional endpoints are needed before these transcriptomic signatures can be interpreted mechanistically or applied clinically.
3) γ-Catenin
Endometrial epithelial γ-catenin, also known as plakoglobin, stabilizes adherens junctions, and desmosomes [40,41]. γ-catenin expression has been reported to increase during the receptive phase of the endometrium, supporting a role in preparing the epithelium for embryo adhesion [42]. Denker [43] showed that lack of γ-catenin is associated with poor junction formation and weakened epithelial integrity.
4) p120-catenin
p120-catenin regulates cadherin stability and turnover at the cell surface, thereby influencing adherens-junction dynamics during implantation. Cyclical mRNA expression of E-cadherin and other catenin family members, including α- and β-catenin, has been reported across the menstrual cycle [6], suggesting that adherens-junction components as a whole, potentially including p120-catenin, may be subject to comparable temporal regulation. Experimental evidence suggests that p120-catenin regulates cadherin endocytosis and recycling, potentially contributing to changes in the adhesive properties of the epithelium during embryo attachment [44].
4. Cadherin–catenin complexes in embryo implantation
The functional interplay between cadherins and catenins coordinates a cascade of cellular events that is critical for successful implantation [45]. This crosstalk regulates three key implantation processes: epithelial remodeling, trophoblast invasion, and decidualization [46].
1) Epithelial remodeling
The endometrial epithelium undergoes substantial remodeling during the receptive phase to permit embryo attachment. Cadherin–catenin complexes regulate the disassembly and reassembly of adherens junctions, thereby modulating epithelial permeability [47]. Although perturbation of E-cadherin appears to be tissue- and region-specific, coordinated regulation of cadherin–catenin complexes contributes to the formation of ‘implantation chambers’ that receive the blastocyst [48,49]. These epithelial changes are illustrated in Figure 1.
2) Trophoblast invasion
After attachment, trophoblasts invade the endometrium to support placental development [50]. Cadherin–catenin complexes at the maternal–fetal interface help regulate the depth and extent of this invasion. Differential cadherin expression on trophoblast cells, mainly N-cadherin, and endometrial cells, mainly E-cadherin, establishes an adhesive gradient that directs the invasive process [19,24]. The molecular interplay regulating trophoblast invasion is schematically represented in Figure 1.
3) Decidualization
Decidualization is the differentiation of endometrial stromal cells into specialized decidual cells that form an implantation-supportive matrix [51]. In this context, N-cadherin-dependent adhesion and β-catenin signaling act together to promote stromal-cell migration and differentiation [15]. Ramathal et al. [52] showed that disruption of these interactions resulted in decidualization failure and, ultimately, implantation failure. The integration of adhesion and signaling mechanisms during decidualization is summarized in Figure 1.
5. Cadherin–catenin signaling within the broader implantation molecular network
Cadherin–catenin complexes do not operate in isolation; rather, they are integrated into the broader molecular network that governs endometrial receptivity and embryo implantation. Their function must therefore be interpreted in the context of the major signaling axes that converge at the maternal–fetal interface.
Among these axes, the leukemia inhibitory factor (LIF)/signal transducer and activator of transcription 3 (STAT3) pathway plays a central role in establishing endometrial receptivity during the window of implantation [53]. LIF-mediated STAT3 activation has been shown to regulate E-cadherin expression in endometrial epithelial cells, providing a mechanistic link between cytokine signaling and cadherin-mediated adhesion remodeling [54,55]. Similarly, integrin-mediated adhesion, particularly αvβ3 integrin expression in the luminal epithelium, cooperates with cadherin dynamics during initial trophoblast attachment, with both systems undergoing coordinated regulation during the receptive phase [55].
The Wnt/β-catenin pathway warrants particular attention in this context. Although β-catenin has been discussed above primarily as a structural component of adherens junctions, its dual role as a transcriptional effector of canonical Wnt signaling makes it a molecular node that integrates adhesion and gene-expression programs [56,57]. Wnt ligand availability, Frizzled receptor activation, and downstream β-catenin nuclear translocation collectively regulate transcription of implantation-related target genes, including cyclin D1, c-Myc, and vascular endothelial growth factor (VEGF), whose products modulate the cellular environment in which cadherin–catenin complexes operate [56,57]. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases constitute another crosstalk axis. MMP-mediated extracellular-matrix remodeling creates a physical microenvironment permissive for trophoblast invasion, and cadherin switching from E-cadherin to N-cadherin in invasive trophoblasts has been shown to upregulate MMP-2 and MMP-9 activity, establishing a bidirectional regulatory relationship between adhesion-molecule dynamics and proteolytic remodeling [58,59].
Transcription factors of the homeobox A (HOXA) family, particularly HOXA10 and HOXA11, are key upstream regulators of cadherin expression in the endometrium. Their cyclical, progesterone-dependent expression during the secretory phase coordinates transcriptional programs involved in epithelial remodeling, including spatiotemporal regulation of E-cadherin downregulation at the implantation site [60,61].
Finally, the immunological microenvironment, shaped by uterine natural killer cells, regulatory T cells, and cytokine networks including interleukin-15 and transforming growth factor-β, modulates trophoblast behavior and cadherin–catenin expression at the maternal–fetal interface. Dysregulation of this immune–adhesion crosstalk has been implicated in RIF and early pregnancy loss [62-65].
Taken together, cadherin–catenin signaling should be understood not as a discrete molecular module but as an interconnected component of the implantation machinery. Its integration with cytokine, growth factor, proteolytic, transcriptional, and immune signaling axes underscores the need for a systems-level perspective when interpreting both its physiological functions and its pathological dysregulation.
6. Pathological implications
Cadherin–catenin complexes are dysregulated in several reproductive disorders, including RIF, early pregnancy loss, and placental pathologies [51].
1) Recurrent implantation failure
Aberrant E-cadherin and β-catenin expression in the endometrial epithelium has been correlated with RIF in women undergoing assisted reproductive technologies [66] and with recurrent miscarriage [13]. Reduced E-cadherin expression may compromise epithelial barrier function, whereas aberrant β-catenin signaling may alter molecular crosstalk between the embryo and decidua [67]. Recent single-cell and spatial transcriptomic studies further indicate that RIF is associated with disrupted epithelial–stromal communication and altered pathway-activation patterns during the mid-luteal phase, reinforcing the translational relevance of cadherin–catenin signaling in human implantation disorders [37-39].
2) Early pregnancy loss
Abnormalities in cadherin–catenin complexes in the decidua have been implicated in early pregnancy loss. Xiong et al. [68] found that low N-cadherin levels in decidual cells were associated with spontaneous abortion, suggesting a role for cadherin-mediated adhesion in embryonic viability.
3) Placental abnormalities
Dysregulation of cadherin–catenin complexes at the maternal–fetal interface is associated with placental abnormalities, including preeclampsia and placenta accreta. Abnormal VE-cadherin expression in the placental vasculature correlates with pathological manifestations of preeclampsia, including impaired placental perfusion and maternal hypertensive disease [23]. Aberrant P-cadherin expression has also been associated with placenta accreta, which is linked to altered trophoblast invasion [17].
Overall, although the pathological associations described above are biologically plausible and supported by directionally consistent evidence, the quality of available evidence is heterogeneous. Many studies are limited by small sample sizes, retrospective designs, and the absence of standardized clinical endpoints. Moreover, most findings in RIF and early pregnancy loss are derived from endometrial tissue sampled at a single time point, which may not capture the dynamic regulation of cadherin–catenin complexes across the implantation window. Causality has rarely been demonstrated in human studies, and mechanistic evidence from animal models does not always align with human observational data. These limitations must be critically appraised before these molecular markers can be considered clinically actionable.
7. Therapeutic and biomarker implications
Understanding the role of cadherin–catenin signaling in embryo implantation has generated interest in its potential clinical relevance. However, established clinical associations should be distinguished from emerging experimental strategies.
1) Established clinical associations
Several studies have reported altered E-cadherin and β-catenin expression patterns in the endometrium of women with RIF or recurrent pregnancy loss [66,67]. These findings suggest that dysregulation of adhesion and Wnt-related signaling pathways may be associated with impaired endometrial receptivity. In addition, transcriptomic and proteomic profiling studies have identified cadherin–catenin-related molecular signatures in endometrial biopsies that correlate with implantation outcomes in assisted reproductive technologies [69].
Although these observations support the potential utility of cadherin–catenin components as biomarkers of endometrial receptivity, the available evidence remains largely correlative. Standardized diagnostic thresholds, large prospective validation studies, and integration into clinical algorithms are still lacking.
Many studies reporting altered E-cadherin or β-catenin expression in infertile women were conducted in populations undergoing assisted reproductive technologies, which introduces potential selection bias. The endometrial biopsy procedure itself, ovarian stimulation protocols, and confounding conditions such as endometriosis or adenomyosis may affect cadherin–catenin expression independently of implantation capacity, limiting the specificity of these markers.
2) Emerging and experimental approaches
Preclinical investigations have explored modulation of cadherin expression and pharmacological regulation of Wnt/β-catenin signaling as potential strategies to improve implantation outcomes. For example, experimental modulation of E-cadherin expression in animal models has been associated with improved receptivity parameters [70]. Similarly, small-molecule regulators of Wnt/β-catenin signaling have been shown to influence decidualization and implantation-related pathways in preclinical settings [71].
However, these approaches remain investigational. To date, no cadherin- or Wnt-targeted therapies have been approved for the treatment of implantation disorders, and clinical translation remains at an early stage. Additional mechanistic studies and well-designed clinical trials are needed to determine safety, specificity, and therapeutic efficacy.
Overall, cadherin–catenin signaling provides a biologically plausible framework for understanding implantation disorders, but its direct therapeutic application requires cautious interpretation and further validation.
Limitations of current evidence
Despite substantial progress in understanding cadherin–catenin signaling during implantation, several limitations should be acknowledged.
First, a substantial proportion of mechanistic evidence comes from murine knockout models. Although these models provide strong causal evidence, species-specific differences in implantation strategy and endometrial physiology may limit direct extrapolation to human reproduction. Second, many human studies are observational and rely on endometrial biopsies obtained during assisted reproductive procedures. These studies are often limited by small sample sizes, heterogeneous patient populations, and variable definitions of conditions such as RIF. Third, although in vitro decidualization models are valuable for mechanistic exploration, they may not fully replicate the complex endocrine, immune, and mechanical microenvironment present in vivo during the implantation window. Fourth, contradictory findings have been reported regarding the temporal regulation of E-cadherin and β-catenin expression across species and experimental systems, suggesting that context-dependent regulation and methodological differences may influence reported outcomes. Finally, although emerging transcriptomic and single-cell approaches have refined cell-type-specific signaling landscapes, longitudinal human studies directly linking cadherin–catenin dynamics to clinical implantation outcomes remain limited.
Addressing these gaps through integrative multi-omics, standardized clinical definitions, and translational studies will be essential for strengthening the clinical applicability of current knowledge.
Future directions
Despite substantial progress in elucidating the contributions of cadherins and catenins to embryo implantation, many questions remain. Future studies should address the following issues.
1. Temporal and spatial dynamics of cadherin–catenin complexes during the window of implantation
Such studies would expand our understanding of the molecular mechanisms governing this process. Advanced in vivo imaging methods, such as super-resolution microscopy and intravital imaging, may reveal the in vivo dynamics of these interactions [72]. Integrating single-cell and spatial transcriptomics with functional pathway analysis, particularly analyses focused on Wnt/β-catenin signaling and adhesion networks, may provide mechanistic clarity and support the development of more precise biomarkers of endometrial receptivity.
2. Epigenetic regulation
Studying the epigenetic regulation of cadherin and catenin genes may provide deeper insight into the molecular basis of endometrial receptivity. Preliminary investigations suggest that transcription of these genes in the endometrium is regulated across the menstrual cycle through DNA methylation and histone modifications [73].
3. Interspecies differences
Comparative studies of implantation across species would help determine whether cadherin–catenin complexes are conserved or divergent across reproductive systems. Such studies could inform evolutionary perspectives and identify species-specific adaptations related to reproductive success [4].
Conclusion
Cadherins and catenins are critical regulators of the cellular events involved in embryo implantation. Their coordinated actions control epithelial remodeling, trophoblast invasion, and decidualization, which are essential steps in establishing a functional maternal–fetal interface. The clinical relevance of these molecular interactions is supported by associations between their dysregulation and reproductive disorders. By clarifying the molecular network governing cadherin–catenin interactions and their roles as mediators of key implantation-related signaling cascades, this review contributes to implantation biology and may inform future research on therapeutic strategies for reproductive disorders.
Notes
Conflict of interest
No potential conflict of interest relevant to this article was reported.
Author contributions
Conceptualization: FC, MPDM. Methodology: FC, AG. Formal analysis: FC, MPDM. Data curation: FC, ARB. Project administration: DC. Visualization: DC. Software: AG, ARB. Validation: ARB, DC. Investigation: FC, MPDM, AG, ARB. Supervision: DC. Writing-original draft: FC, MPDM, AG, ARB, DC. Writing-review & editing: FC, MPDM, AG, ARB, DC. Approval of final manuscript: FC, MPDM, AG, ARB, DC.
